The United States Centers for Disease Control and Prevention (CDC) today announced that it has issued a Health Alert Network (HAN) Health Advisory CDCHAN-00463 inform health care providers, public health departments and the public about the availability and use of recommended therapies for COVID-19.
Additionally, today’s HAN advises against the use of unproven treatments that have known or potential harmful effects for outpatients with mild to moderate COVID-19.
For patients with mild to moderate COVID-19 who are not hospitalized and who are at increased risk of serious COVID-19-related outcomes, several treatment options are now available available and accessible.
However, since April 8, 2022, systemic corticosteroids are not recommended to treat patients with mild to moderate COVID-19 who do not require supplemental oxygen.
Or patients receiving dexamethasone or another corticosteroid for other indications should continue treatment for their underlying conditions as directed by their healthcare providers.
And antibacterial therapy is not recommended for the treatment of COVID-19 in the absence of another clinical indication and offers no benefit in the treatment of viral infections.
“Staying up to date with the COVID-19 vaccination is still the best way to prevent serious consequences from COVID-19, including serious illness, hospitalizations, and death,” the CDC says.
US National Institutes of Health releases updates to COVID-19 treatment guidelines at this link.
The guidelines committee also recommends against using antibacterial treatment for COVID-19 without further indication.
The latest news on COVID-19 treatments is posted at PrecisionVaccinations.com/Antivirals.